Literature DB >> 2292020

Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection.

T J Coderre1, A L Vaccarino, R Melzack.   

Abstract

Evidence is presented which suggests that central neural changes occur during the brief early phase after subcutaneous formalin injection that are essential for the expression of pain during the long-lasting (tonic) later phase. First, tonic pain responses to subcutaneous formalin injections are abolished only if the injected hindpaw is locally anesthetized at the time of injection as well as the time of testing (30-60 min later). Second, tonic formalin pain is substantially reduced by brief spinal anesthesia given 5 min before, but not 5 min after the formalin injection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292020     DOI: 10.1016/0006-8993(90)91835-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  65 in total

1.  GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.

Authors:  H Rogers; P J Birch; S M Harrison; E Palmer; G R Manchee; D B Judd; A Naylor; D I Scopes; A G Hayes
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Pharmacol Biochem Behav       Date:  2011-09-17       Impact factor: 3.533

3.  D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain.

Authors:  Jin-Miao Lu; Nian Gong; Yan-Chao Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 4.  [Potential antinociceptive mechanisms of botulinum toxin].

Authors:  K R Aoki; J Francis; W H Jost
Journal:  Schmerz       Date:  2006-09       Impact factor: 1.107

5.  Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo.

Authors:  Gabriella Aviello; Francesca Borrelli; Francesca Guida; Barbara Romano; Kevin Lewellyn; Maria De Chiaro; Livio Luongo; Jordan K Zjawiony; Sabatino Maione; Angelo A Izzo; Raffaele Capasso
Journal:  J Mol Med (Berl)       Date:  2011-04-16       Impact factor: 4.599

6.  The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.

Authors:  J Guindon; J Desroches; P Beaulieu
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

7.  Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Authors:  Joel M Brittain; Djane B Duarte; Sarah M Wilson; Weiguo Zhu; Carrie Ballard; Philip L Johnson; Naikui Liu; Wenhui Xiong; Matthew S Ripsch; Yuying Wang; Jill C Fehrenbacher; Stephanie D Fitz; May Khanna; Chul-Kyu Park; Brian S Schmutzler; Bo Myung Cheon; Michael R Due; Tatiana Brustovetsky; Nicole M Ashpole; Andy Hudmon; Samy O Meroueh; Cynthia M Hingtgen; Nickolay Brustovetsky; Ru-Rong Ji; Joyce H Hurley; Xiaoming Jin; Anantha Shekhar; Xiao-Ming Xu; Gerry S Oxford; Michael R Vasko; Fletcher A White; Rajesh Khanna
Journal:  Nat Med       Date:  2011-06-05       Impact factor: 53.440

8.  Systemic minocycline differentially influences changes in spinal microglial markers following formalin-induced nociception.

Authors:  Kai Li; Kai-Yuan Fu; Alan R Light; Jianren Mao
Journal:  J Neuroimmunol       Date:  2010-03-04       Impact factor: 3.478

9.  Regional changes in forebrain activation during the early and late phase of formalin nociception: analysis using cerebral blood flow in the rat.

Authors:  T J Morrow; P E Paulson; P J Danneman; K L Casey
Journal:  Pain       Date:  1998-04       Impact factor: 6.961

10.  Signal changes in the spinal cord of the rat after injection of formalin into the hindpaw: characterization using functional magnetic resonance imaging.

Authors:  R Pórszász; N Beckmann; K Bruttel; L Urban; M Rudin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.